FDA DEVICE FACTS
Elite Expandable Interbody Fusion Device
Spineology, Inc.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
Elite™ Expandable implants are intervertebral body fusion devic es indicated for intervertebral body fusion at one level or two contiguous levels in the lumbar spine from L2 to S1 in patients with degenerative disc disease (DDD) with up to Grade 1 spondyl olisthesis at the involved level(s). DDD is defined as back pain of discogenic origin with d e g e n e r a t i o n o f t h e d i s c c o n f i r m e d b y p a t i e n t h i s t o r y a n d r a d i o g r a p h i c s t u d i e s . T h e s e p at i e n t s s h o u l d b e s k e l e t a l l y mature and have had six months of non-operative treatment.
Elite™ Expandable implants are designed for use with autograft and/or allograft comprised of cancellous and/or corticocancellous bone graft as an adjunct to fusion and are intended for use with supplemental fixation systems cleared by the FDA for use in the lumbar spine.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。